EquasensFRA:PHF 98 Gross Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:PHF with a GF Score™ of 98/100 and a GF Value™ of €85.23. The stock has 2 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Equasens ranks better than 77.58% on this metric.
The historical rank and industry rank for Equasens's Gross Margin % or its related term are showing as below:
FRA:PHF'
s Gross Margin % Range Over the Past 10 Years
Min: 64.06 Med: 68.48 Max: 69.46
Current: 68.74
During the past 13 years, the highestGross Margin % of Equasens was 69.46%. The lowest was 64.06%. And the median was 68.48%.
FRA:PHF's Gross Margin % is ranked better than 77.58% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs FRA:PHF: 68.74
Equasens had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Equasens was -0.20% per year.
Equasens (FRA:PHF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Equasens had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Equasens Gross Margin % Related Terms
Equasens Gross Margin % Historical Data
* Premium members only.
The historical data trend for Equasens's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PHF vs VEEV, BTSG, TEM: Gross Margin % Comparison
For the Health Information Services subindustry, Equasens's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Equasens Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Equasens's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Equasens's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Equasens (FRA:PHF) has a Gross Margin % of 0.00% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Equasens and its competitors. Over the past decade, Equasens' Gross Margin % has ranged from 64.06 to 69.46. According to the industry distribution chart, Equasens ranks #141 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 22.4%.
Is Equasens' Gross Margin % too high?
Equasens' current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 64.06 to a high of 69.46. Based on the distribution chart, Equasens ranks #141 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Equasens has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Equasens' Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Equasens ranks #141 out of 629 companies for Gross Margin %. This places Equasens in the top 22% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. Historically, Equasens' own Gross Margin % has ranged from 64.06 to 69.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Equasens and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Equasens's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Equasens stock overvalued right now?
Equasens (FRA:PHF) has a current Gross Margin % of 0.00%. The stock's GF Value™ is €85.23, compared to a current price of €52.77 — trading 38.1% below its estimated fair value. The current Gross Margin % is 0.00%. Equasens' overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Equasens (FRA:PHF), the current Gross Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Equasens (FRA:PHF) Overvalued in 2026?
Based on GuruFocus' analysis, Equasens stock appears to be undervalued.
The current stock price of €52.77 is trading 38.1% below its estimated GF Value™ of €85.23.
Key valuation signals for FRA:PHF:
Gross Margin %: 0.00%
GF Value™: €85.23 vs. price of €52.77 (38.1% below fair value)
No single metric tells the full story. See the FRA:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
98GF Score
Get the complete analysis for FRA:PHF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHF has been successfully added to your 
